Fresh Tracks Therapeutics (FRTX) has released an update.
Fresh Tracks Therapeutics, Inc. stockholders convened for a crucial vote on the company’s future, deciding whether to approve its liquidation and dissolution. While the proposal to adjourn the meeting, if needed, to gather more votes passed effortlessly, the more consequential decision on liquidation did not secure the necessary majority from outstanding shares. Despite a majority present voting for it, the lack of overall majority support means the company won’t proceed with the dissolution as proposed.
For further insights into FRTX stock, check out TipRanks’ Stock Analysis page.
